Skye Bioscience, Inc. (SKYE) Total Assets by Year
Skye Bioscience, Inc. closed fiscal year 2025 with $28.3M in total assets, $8.3M in total liabilities and $20.0M in shareholder equity. This represents a decrease of 61.1% from the prior fiscal year. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Skye Bioscience, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SKYE Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $28.3M-61.1% | $72.8M+509.4% | $11.9M+31.1% | $9.1M-7.5% | $9.9M+268.9% | $2.7M+33.8% | $2.0M+2.0% | $2.0M+251.2% | $557K+72.3% | $323K-90.8% | $3.5M+907.9% | $348K+147.3% | $141K+228.4% | $43K |
| Total Liabilities | $8.3M+79.7% | $4.6M-67.2% | $14.1M+16.1% | $12.1M+203.7% | $4.0M+79.7% | $2.2M+53.3% | $1.4M-91.7% | $17.5M+324.5% | $4.1M+27.5% | $3.2M-26.5% | $4.4M+449.1% | $802K+148.3% | $323K+7368.0% | $4K |
| Total Equity | $20.0M-70.6% | $68.2M+3296.9% | -$2.1M+29.1% | -$3.0M-151.3% | $5.9M+1200.9% | $451K-17.7% | $548K+103.5% | -$15.6M-336.0% | -$3.6M-22.5% | -$2.9M-226.6% | -$892K-96.7% | -$454K-149.0% | -$182K-572.4% | $39K |
SKYE Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.0M-78.8% | $19.4M-70.0% | $28.3M-61.1% | $41.3M-49.3% | $52.2M-40.2% | $64.8M-31.7% | $72.8M+509.4% | $81.5M+422.5% | $87.3M+3802.7% | $94.8M+1967.5% | $11.9M+31.1% | $15.6M+443.9% |
| Total Liabilities | $11.5M+35.9% | $10.4M+87.7% | $8.3M+79.7% | $8.5M+48.1% | $8.5M-41.3% | $5.5M-65.3% | $4.6M-67.2% | $5.7M-58.8% | $14.5M+44.2% | $16.0M+70.3% | $14.1M+16.1% | $13.9M+126.0% |
| Total Equity | -$497K-101.1% | $9.0M-84.8% | $20.0M-70.6% | $32.8M-56.7% | $43.7M-40.0% | $59.3M-24.9% | $68.2M+3296.9% | $75.8M+4371.5% | $72.8M+1034.7% | $78.9M+1750.1% | -$2.1M+29.1% | $1.7M+151.6% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Skye Bioscience, Inc. financials
Frequently Asked Questions
What was Skye Bioscience, Inc.'s total assets in fiscal year 2025?
Skye Bioscience, Inc. closed fiscal year 2025 with $28.3M in total assets, $8.3M in total liabilities and $20.0M in shareholder equity.
How fast is Skye Bioscience, Inc.'s total assets growing?
Skye Bioscience, Inc. (SKYE) total assets fell by 61.1% year over year, from $72.8M to $28.3M in fiscal year 2025.
How has Skye Bioscience, Inc.'s total assets changed over the years?
Across the 14 fiscal years this page covers, Skye Bioscience, Inc. (SKYE) total assets went from $43K in fiscal year 2012 to $28.3M in fiscal year 2025.
What was Skye Bioscience, Inc.'s total assets in the most recent quarter?
Skye Bioscience, Inc. (SKYE) reported $11.0M in total assets in Q2 2026. This represents a decrease of 78.8% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Skye Bioscience, Inc. (SKYE) reported on that line in every period on record.